Biophytis Statistics
Total Valuation
Biophytis has a market cap or net worth of 3.40 million. The enterprise value is 12.18 million.
| Market Cap | 3.40M |
| Enterprise Value | 12.18M |
Important Dates
The next estimated earnings date is Friday, September 26, 2025.
| Earnings Date | Sep 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +84.55% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 22.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.49 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.75 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.05 |
Financial Position
The company has a current ratio of 0.41
| Current Ratio | 0.41 |
| Quick Ratio | 0.39 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.90 |
| Interest Coverage | -8.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -65.37% |
| Return on Invested Capital (ROIC) | -119.47% |
| Return on Capital Employed (ROCE) | 226.87% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -734,150 |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.65% in the last 52 weeks. The beta is 0.30, so Biophytis's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -78.65% |
| 50-Day Moving Average | 1.83 |
| 200-Day Moving Average | 2.98 |
| Relative Strength Index (RSI) | 28.20 |
| Average Volume (20 Days) | 57 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.07M |
| Pretax Income | -16.16M |
| Net Income | -16.15M |
| EBITDA | -12.65M |
| EBIT | -13.07M |
| Earnings Per Share (EPS) | -5.99 |
Balance Sheet
The company has 2.35 million in cash and 10.40 million in debt, giving a net cash position of -8.06 million.
| Cash & Cash Equivalents | 2.35M |
| Total Debt | 10.40M |
| Net Cash | -8.06M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -6.88M |
| Book Value Per Share | -1.31 |
| Working Capital | -8.94M |
Cash Flow
In the last 12 months, operating cash flow was -11.43 million and capital expenditures -148,934, giving a free cash flow of -11.58 million.
| Operating Cash Flow | -11.43M |
| Capital Expenditures | -148,934 |
| Free Cash Flow | -11.58M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Biophytis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -307.72% |
| Shareholder Yield | n/a |
| Earnings Yield | -475.47% |
| FCF Yield | -340.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 23, 2024. It was a reverse split with a ratio of 0.025.
| Last Split Date | Apr 23, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.025 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |